Last reviewed · How we verify
NCT04617262: PM+
Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19
NA trial testing Remote Problem Management Plus in Depression in 45 participants. Completed in 20 May 2023.
20 February 2023
Quick facts
| Lead sponsor | The New School |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 4 March 2021 |
| Primary completion | 20 February 2023 |
| Estimated completion | 20 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Remote Problem Management Plus
Conditions studied
- Depression — all drugs for Depression →
- Anxiety Disorders — all drugs for Anxiety Disorders →
- Psychological Distress — all drugs for Psychological Distress →
Sponsor
The New School
Who can join
18 and older, any sex, with Depression or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a pilot feasibility study of remotely delivered Problem Management Plus, a low-intensity psychological intervention, delivered in five sessions to adults affected by crisis. The current study will evaluate the feasibility and acceptability of the intervention when delivered remotely via Zoom to community members in New York City impacted by the COVID-19 pandemic. The investigator's goal is to use qualitative and quantitative approaches to inform procedures for a subsequent cluster randomized control trial of Problem Management Plus versus enhanced usual care. A mixed-methods design will be used to evaluate the feasibility, acceptability, perceived utility, and impact of the remotely delivered PM+ intervention, to determine recruitment and retention rates, to assess ethics and safety of trial procedures. Additionally, the study will evaluate the acceptability, feasibility and fidelity of the remote training and supervision of helpers trained to deliver the intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04617262
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other The New School trials
Trials by the same sponsor.
- NCT06934954 — Early Adolescent Skills for Emotions · NA · recruiting
- NCT07208851 — Developing a Booster Session for Problem Management Plus in the Bahamas: A Pilot Randomized Controlled Trial · NA · recruiting
- NCT05477355 — Adapting Group PM+ for Venezuelan Refugees and Migrants in Colombia · NA · unknown
- NCT06140498 — Effects of Self-Efficacy Ecological Momentary Intervention (EMA) App · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04617262 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The New School
- Last refreshed: 22 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04617262.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing